Probiotics and methods of use
AssigneeH.J. Heinz Company Brands LLC
InventorsFrancesca Romana Fasano, Maria Rescigno
Life of this patent
Estimating the term…
Abstract
The present invention features methods for treating or reducing the severity of a microbial infection in an infant of a lactating mother. Compositions comprising food products fermented by Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778 are administered to a pregnant or lactating mother in order to treat or attenuate the severity of a microbial infection in her offspring.
Claims11
A method of treating a microbial infection in an infant of a lactating mother, the method comprising administering an effective amount of a composition comprising a food product to the mother, wherein the food product has been fermented by the probiotic bacterium, Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778, and the probiotic bacterium rendered non-replicating after fermentation, wherein the concentration of the probiotic bacterium in the food product is at least 1×107 colony forming units (CFU) per gram as calculated prior to rendering the probiotic bacterium non-replicating after fermentation, wherein the microbe causing the infection being treated is at least one of Salmonella typhimurium and Cronobacter sakazakii.
A method of reducing the severity of a bacterial infection in an infant of a lactating mother, the method comprising administering an effective amount of a composition comprising a food product to the mother, wherein the food product has been fermented by the probiotic bacterium, Lactobacillus paracasei CBA L74, International Depository Accession Number LMG P-24778, and the probiotic bacterium rendered non-replicating after fermentation, wherein the concentration of the probiotic bacterium in the food product is at least 1×107 colony forming units (CFU) per gram as calculated prior to rendering the probiotic bacterium non-replicating after fermentation, wherein the microbe causing the infection being treated is at least one of Salmonella typhimurium and Cronobacter sakazakii.
Dependencies are inferred from the claim text.